PALM BEACH GARDENS, Fla., July 31 /PRNewswire-FirstCall/ -- MediSys Corporation is pleased to announce that president Joshua Konigsberg will conduct an interview with WallSt.net at 12 p.m. Eastern Time on July 31st. The interview will be posted on WallSt.net within one hour of it being conducted.
Mr. Konigsberg will field questions regarding MediSys and the market in general such as recent activity and recent news from MediSys Corporation, including the executed distribution agreement with Innovative Practice Solutions of Atlanta Georgia and the recent study commissioned by Schering-Plough and Glaxo Smith Kline, which validates the MediSys MaxLife Center for Men Medical Model.
To hear the interview in its entirety, visit www.wallst.net , and click on "Interviews." Interviews require free registration, and can be accessed either by locating the company's ticker symbol MDYS under the appropriate exchange on the left-hand column of the "Interviews" section of the site, or by entering the company's ticker symbol MDYS in the Search Archive window.
About WallSt.net
WallSt.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The website is a leading provider of financial news, media, tools and community-driven applications for investors. www.wallst.net offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications. In addition to its website, WallStreet Direct organizes investor conferences, publishes a newspaper, and provides multimedia advertising solutions to small and mid-sized publicly traded companies.
About MediSys
MediSys Corporation provides medical diagnostic solutions to physicians in the internal medicine, family medicine and general practice markets. The Company's innovative clinical programs are easily integrated into the physicians practice, are cost-effective and enhance patient care. These programs or "systems" enable doctors to provide superior medical diagnostics & treatment while significantly improving their revenues and profits.
Disclaimer Regarding Forward-Looking Statements:
This announcement may contain certain forward-looking statements that are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated. Forward-looking statements speak only as of the date the statement was made. The Company assumes no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. If the Company does update any forward-looking statement, no inference should be drawn that the Company will make additional updates with respect to that statement or any other forward-looking statements.
Contact: Brian Gibson 800 Village Square Crossing Suite 201 Palm Beach Gardens, FL 33410 Tel: 561-622-5889 Fax: 561-656-2099 e-mail: investor-relations@medisyscorp.comwww.medisyscorp.com
MediSys CorporationCONTACT: Brian Gibson of MediSys Corporation, +1-561-622-5889, or fax,+1-561-656-2099, investor-relations@medisyscorp.com